Xtant Medical Appoints Scott Neils Interim Chief Financial Officer
Xtant Medical Holdings, Inc. (NYSE American: XTNT) has appointed Scott Neils as Interim Chief Financial Officer, effective January 3, 2022. Neils, who has 15 years of experience in public accounting and corporate finance, previously served as the Company’s Controller since August 2019. His promotion follows the tenure of Greg Jensen, who has led the finance team for nearly three years. Neils' extensive experience in finance will be pivotal for the Company as it continues to focus on surgical solutions for spinal disorders, ensuring stability during this transitional phase.
- Promotion of Scott Neils as Interim CFO, expected to bring continuity and experience to the finance team.
- Transition may raise concerns regarding continuity and potential gaps in financial leadership during the changeover.
BELGRADE, Mont., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Interim Chief Financial Officer succeeding Greg Jensen, the Company’s current Vice President, Finance and Chief Financial Officer, effective January 3, 2022.
“We are excited to announce this well deserved promotion for Scott. His demonstrated ability to oversee the Company’s finance and accounting operations in his current role as the Company’s Controller and his depth of experience in accounting will continue to be a great benefit to Xtant Medical,” said Sean Browne, President and Chief Executive Officer of Xtant Medical. “Additionally, we sincerely thank Greg for his dedication, leadership and lasting impact on the Company during his almost three-year tenure with the Company.”
Mr. Neils has 15 years of experience focused on public accounting and corporate finance and has served as the Company’s Controller since August 2019. In this role, Mr. Neils gained extensive experience managing the Company’s finance and accounting functions. Prior to joining Xtant Medical, Mr. Neils served as Audit Senior Manager at Baker Tilly US, LLP (formerly Baker Tilly Virchow Krause, LLP), an advisory, tax and assurance firm, from November 2015 to August 2019. Prior to that position, Mr. Neils was at Grant Thornton LLP, an accounting and advisory organization, from September 2007 to November 2015, most recently as Audit Manager. Mr. Neils is a Certified Public Accountant. He holds a Bachelor of Science in Business in Accounting and a Master of Accountancy from the Carlson School of Management at the University of Minnesota.
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant’s people are dedicated and talented, operating with the highest integrity to serve Xtant’s customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
David Carey
Lazar FINN
Ph: 212-867-1762
Email: david.carey@finnpartners.com
FAQ
Who is the new CFO of Xtant Medical Holdings?
What is the background of Scott Neils?
Why did Greg Jensen leave Xtant Medical?
When did Scott Neils start his role as Interim CFO?
What impact might this leadership change have on Xtant Medical?
